Dusseldorf - Delayed Quote • EUR Genscript Biotech Corp (G51.DU) Follow Compare 1.2600 0.0000 (0.00%) At close: January 31 at 7:30:32 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations GenScript's 2025 JPM Global Forum Concludes Successfully in San Francisco GenScript Biotech, a global biotechnology leader in life science, biologics manufacturing, synthetic biology, and cell therapies announced the successful conclusion of its 2025 JPM Global Forum held on January 15 in San Francisco. The event, themed "Challenges and Opportunities of Cell and Gene Therapy in the New Era," attracted more than 700 attendees both in person and via live-stream, featuring a series of keynote speeches and panel discussions that offered insights into the future of cell an 3 Leading Stocks Estimated To Be Up To 49.3% Below Their Intrinsic Value In the current global market landscape, cooling inflation in the U.S. and robust bank earnings have driven major stock indexes higher, with value stocks outperforming growth shares significantly. Amid these developments, identifying undervalued stocks becomes crucial as they offer potential opportunities for investors looking to capitalize on discrepancies between market prices and intrinsic values. Performance Overview Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX Return G51.DU HANG SENG INDEX YTD +8.62% +0.92% 1-Year +8.62% +28.79% 3-Year +8.62% -14.12%